Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | Ethics, Clinical Practice, and Challenges in Neurogeriatric Care for the 21st Century

Thursday 04/15/10
02:15 PM - 06:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
PM Half-Day Course
Jerome E. Kurent, MD, MPH, FÂ鶹´«Ã½Ó³»­
Aging/Dementia/Degenerative Disease, Practice Management
Participants should have an increased ability to solve medical-ethical dilemmas confronting the neurologist in providing comprehensive ethical care for geriatric patients with life-limiting neurologic disease; have an enhanced appreciation for obtaining informed consent, respecting patient autonomy, and determing medical decision-making capacity and competence, and the role of advance directives for the patient with dementia; be able to discuss ethical dimensions of diagnostic testing of asymptomatic individuals at risk for developing dementia; and have an enhanced knowledge of perceived medical futility, as well as evidence for and against artificial hydration and nutrition in the patient with advanced dementia.
No CME available
Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Advanced
Practitioner, Fellow, Academician, Resident, Other
Event Timeline
02:15 PM - 02:30 PM Introduction: The Increasing Burden of Neurologic Disease in Our Rapidly Aging Population
Jerome E. Kurent, MD, MPH, FÂ鶹´«Ã½Ó³»­
02:30 PM - 02:55 PM The Patient with Dementia: Defining the Patient-Physician Relationship, Disclosing the Diagnosis, Consent and Competence, and Advance Directives
James L. Bernat, MD, FÂ鶹´«Ã½Ó³»­
02:55 PM - 03:05 PM Questions and Answers
James L. Bernat, MD, FÂ鶹´«Ã½Ó³»­
03:05 PM - 03:30 PM The Role of Apo-E and Other Genetic Tests in Asymptomatic Individuals at Risk for Developing Dementia: to Test, or Not to Test?
Thomas D. Bird, MD, FÂ鶹´«Ã½Ó³»­
03:30 PM - 03:40 PM Questions and Answers
Thomas D. Bird, MD, FÂ鶹´«Ã½Ó³»­
03:40 PM - 04:05 PM Ethical Issues Related to Research Participation by Patients Diagnosed with Dementia
Jason H. Karlawish, MD
04:05 PM - 04:15 PM Questions and Answers
Jason H. Karlawish, MD
04:15 PM - 04:30 PM Break
04:30 PM - 04:55 PM Can Perceived Medical Futility Be Defined, or Does Futility Mean Different Things to Different People? Are There Practical Limits to Providing Care and Caring?
Robert Pearlman, MD, MPH
04:55 PM - 05:05 PM Questions and Answers
Robert Pearlman, MD, MPH
05:05 PM - 05:30 PM Tube Feeding for the Terminally Ill Patient With Alzheimer's Disease: Weighing the Evidence for and Against, with Review of American Academy of Hospice and Palliative Medicine Guidelines
Jerome E. Kurent, MD, MPH, FÂ鶹´«Ã½Ó³»­
05:30 PM - 05:40 PM Questions and Answers
Jerome E. Kurent, MD, MPH, FÂ鶹´«Ã½Ó³»­
05:40 PM - 06:00 PM Discussion
Faculty Disclosures
Jerome E. Kurent, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Kurent has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Young Clement Rivers, LLP.
James L. Bernat, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bernat has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Physician's Index for Ethics in Medicine. The institution of Dr. Bernat has received research support from National Institutes of Health UL1TR001086. The institution of Dr. Bernat has received research support from National Institutes of Health ME-1609-36174. Dr. Bernat has received publishing royalties from a publication relating to health care.
Thomas D. Bird, MD, FÂ鶹´«Ã½Ó³»­ Dr. Bird has nothing to disclose.
Robert Pearlman, MD, MPH No disclosure on file
Jason H. Karlawish, MD No disclosure on file